SK Capital Closes $800M Sophomore Fund for Specialty Materials, Life Sciences

SK Capital Partners, a private investment firm focused on the specialty materials, ingredients and life sciences sectors, closed its second fund, SKCP Catalyst Fund II, at $800 million, reflecting the fund’s $750 million hard cap and the firm’s additional $50 million investment.

SK Capital applies the same investment process and principles across its entire portfolio and invests capital from two parts of the SK Capital fund family: Flagship and Catalyst.

The Flagship strategy currently focuses on the upper mid-sized and large companies, while the Catalyst strategy, founded in 2019, is dedicated to the lower middle market companies.

Since its founding in 2007, SK Capital has raised seven funds and has over $7.8 billion of assets under management across both strategies.

“The successful fundraise is a recognition of the Firm’s ability to deliver value across the deal size spectrum in our sectors of focus, and in particular our ability to capture value and generate distributions in a challenging market,” said Barry Siadat, Co-Founder and Managing Director of SK Capital.

The fund focuses on buyout investments that generally require initial capital of up to $100 million. The predecessor fund had aggregate commitments of approximately $415 million and has made eight platform investments, two of which have already had significant realizations: the full exit of NuCera Solutions and the majority sale of Techmer PM.